Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin specific peptidase 7 (USP7) is a deubiquitinating enzyme that removes ubiquitin moieties from specific protein substrates, thereby regulating their stability and function. USP7 contains several structural domains, including a N-terminal TRAF-like domain for substrate recognition, a central catalytic domain, and multiple C-terminal ubiquitin-like domains that mediate interactions with various target proteins[1][3][5]. USP7 is essential for modulating pathways such as the p53 tumor suppressor axis, DNA damage response, and multiple epigenetic processes through histone deubiquitination[3][4][5]. Aberrant USP7 activity is linked to tumorigenesis (via p53/MDM2 regulation), immune modulation, and even behaviors associated with drug addiction[1][4][7]. Targeted inhibition of USP7 has emerged as a promising anticancer approach due to its central role in maintaining protein homeostasis and regulating cell fate decisions[1][3][7].
Inhibition of deubiquitinase activity, leading to accumulation of ubiquitinated target proteins and altered stability of substrates such as p53 and MDM2[1][3][7].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin specific peptidase 7 (USP7).